I got hold of a model which has very conservative assumptions puts the company valuation north of USD$360M.Mass recoveries of 60% when the company is indicating potentially 68%.Just a matter of the team putting in the man hours now.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status